ORGO Organogenesis Holdings PE ratio, current and historical analysis
The current PE ratio of ORGO cannot be calculated, as the latest EPS of -$0.06 is negative. The most recent PE ratio recorded for Organogenesis Holdings was 71.0 in March 2024.
ORGO PE ratio history
Over the last five years, the average PE ratio of Organogenesis Holdings has been 34.05. Analyzing the last five years, ORGO's PE ratio reached its highest point in the Dec 2023 quarter at 102.25, with a price of $4.09 and an EPS of $0.04. The Sep 2022 quarter saw the lowest point at 7.2, with a price of $3.24 and an EPS of $0.45.
Organogenesis Holdings PE ratio by year
Maximum annual increase: 356.07% in 2023
Maximum annual decrease: -73.1% in 2021
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | 102.25 | 356.07% | $4.09 | $0.04 |
| 2022 | 22.42 | 77.09% | $2.69 | $0.12 |
| 2021 | 12.66 | -73.1% | $9.24 | $0.73 |
| 2020 | 47.06 | N/A | $7.53 | $0.16 |
| 2019 | N/A | N/A | $4.81 | -$0.42 |
| 2018 | N/A | N/A | $10.15 | -$0.94 |
| 2017 | N/A | N/A | $9.92 | -$0.14 |
| 2016 | N/A | N/A | N/A | -$0.27 |
Organogenesis Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | N/A | N/A | $2.86 | -$0.06 |
| Jun 2024 | N/A | N/A | $2.8 | -$0.13 |
| Mar 2024 | 71 | -30.56% | $2.84 | $0.04 |
| Dec 2023 | 102.25 | 221.54% | $4.09 | $0.04 |
| Sep 2023 | 31.8 | -23.37% | $3.18 | $0.1 |
| Jun 2023 | 41.5 | 114.36% | $3.32 | $0.08 |
| Mar 2023 | 19.36 | -13.65% | $2.13 | $0.11 |
| Dec 2022 | 22.42 | 211.39% | $2.69 | $0.12 |
| Sep 2022 | 7.2 | -18.83% | $3.24 | $0.45 |
| Jun 2022 | 8.87 | -25.52% | $4.88 | $0.55 |
| Mar 2022 | 11.91 | -5.92% | $7.62 | $0.64 |
| Dec 2021 | 12.66 | -54.66% | $9.24 | $0.73 |
| Sep 2021 | 27.92 | 2.46% | $14.24 | $0.51 |
| Jun 2021 | 27.25 | -40.18% | $16.62 | $0.61 |
| Mar 2021 | 45.55 | -3.21% | $18.22 | $0.4 |
ORGO average PE ratio chart
ORGO PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| OPTN OptiNose Inc | N/A | $61.14M |
| OPK Opko Health Inc | N/A | $1.03B |
| ORGO Organogenesis Holdings Inc | N/A | $499.81M |
Frequently asked questions
What is Organogenesis Holdings's PE ratio?
The current price to earnings ratio of ORGO cannot be determined, as its EPS of -$0.06 is negative.
What is the 3-year average PE ratio for Organogenesis Holdings (ORGO)?
Over the last 3 years, the average PE ratio for ORGO stock is 35.15.
What is the 5-year average PE ratio for Organogenesis Holdings (ORGO)?
Over the last 5 years, the average PE ratio for ORGO stock is 34.05.
What is the highest PE ratio for ORGO?
Over the last five years, the Dec 2023 quarter recorded the highest quarterly PE ratio at 102.25.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.